Tetrahydroquinolinones and their use as antagonists of...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 215/54 (2006.01) C07D 215/20 (2006.01) C07D 215/22 (2006.01) C07D 215/36 (2006.01) C07D 221/06 (2006.01) C07D 221/22 (2006.01) C07D 401/04 (2006.01) C07D 401/10 (2006.01) C07D 401/12 (2006.01) C07D 407/04 (2006.01) C07D 407/12 (2006.01) C07D 409/04 (2006.01) C07D 413/06 (2006.01) C07D 417/04 (2006.01) C07D 417/06 (2006.01)

Patent

CA 2556653

The invention relates to tetrahydroquinolinone derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are group I mGluR antagonists and are therefore useful for the control and prevention of acute and/or chronic neurological disorders. (see formula IA)

L'invention concerne des dérivés de tétrahydroquinolinone ainsi que leurs sels pharmaceutiquement acceptables. L'invention concerne également un procédé permettant de préparer ces composés. Les composés de l'invention sont des antagonistes mGluR du groupe I et sont, de ce fait, utilisés pour contrôler et prévenir les troubles neurologiques aigus et/ou chroniques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Tetrahydroquinolinones and their use as antagonists of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tetrahydroquinolinones and their use as antagonists of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydroquinolinones and their use as antagonists of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1926724

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.